Sector 0818 · PSX: SHFA
Shifa International Hospitals Limited (SHFA)
LAST PRICE (PKR)
450.71
+0.17% · vol 3.7K
LIVE PSX quote · updated 18:14:33 PKT · open the real-time board
Forecast for SHFA
Strong Sell · score 19/100 · 85% confidenceNext session target
449.30
-0.31% · band 443.66–454.94
1 week target
442.30
-1.87% · band 429.69–454.91
1 month target
428.70
-4.88% · band 402.25–455.16
Levels
450.23 / 543.69
support / resistance · RSI 9.04
Open the full SHFA forecast model →
Quantitative model output for education and research. Not investment advice.
Market Cap
—
P/E Ratio
—
trailing
Dividend Yield
—%
trailing
ROE
—%
return on equity
Debt / Equity
—
leverage
Revenue Growth
—
YoY
Profit Growth
—
YoY
52W Range
— – —
PKR
SHFA price trend
Last 75 sessions2026-08-162026-10-29
AI Company Intelligence — Shifa International Hospitals Limited
Business model, growth drivers, risks and investor checklist, generated from the data on this page.
Why this company matters
- Shifa International Hospitals Limited (traded under the PSX symbol SHFA) is a prominent healthcare provider in Pakistan, known for offering tertiary care medical services.
- The company holds significant importance in Pakistan's healthcare sector, representing the intersection of private medical infrastructure development and urban demographic demand.
- For retail investors, analysts, and students, SHFA provides a window into how defensive consumer sectors navigate macroeconomic shifts in Pakistan, including inflation and currency fluctuations.
Business model and products
- SHFA operates integrated healthcare facilities, primarily centered around its flagship hospital in Islamabad and expanding networks elsewhere.
- Its revenue model relies heavily on inpatient admissions, outpatient consultations, diagnostic laboratories, pharmacy sales, and specialized surgical procedures.
- The business serves a diverse clientele, ranging from self-paying private patients and corporate panels to international medical tourists and panel patients from various institutions.
Market presence
- SHFA occupies a strong brand position in the twin cities of Islamabad and Rawalpindi, acting as a regional hub for advanced medical care.
- It competes with other prominent private hospital networks and specialized medical centers operating within Pakistan's urban centers.
- The company benefits from a loyal patient base built on its reputation for clinical quality and specialized medical expertise.
Financial highlights
- The last recorded market price for SHFA stands at 450.71 PKR, reflecting a minor positive change of +0.17%.
- Specific quantitative metrics such as market capitalization, price-to-earnings (P/E) ratio, dividend yield, debt-to-equity ratio, and return on equity (ROE) are currently unlisted or unavailable in the active dataset.
- Financial evaluations require referencing the company’s latest quarterly and annual financial statements available on the Pakistan Stock Exchange portal.
Revenue and profit trend
- Specific historical figures for revenue growth and profit growth are not detailed in the current dataset.
- Generally, healthcare providers in Pakistan experience steady top-line growth driven by healthcare inflation and rising demand for quality medical services.
- Profitability trends are frequently influenced by escalating utility tariffs, medical equipment import costs, and staff retention expenses.
Dividend and balance sheet
- Specific data regarding current dividend yields and balance sheet ratios (such as Debt/Equity) are not provided in the current dataset.
- Historically, capital-intensive healthcare operators must balance debt financing for expansion projects against internal cash generation for dividend payouts.
- Investors should consult the latest audited financial reports to assess the company's leverage, working capital management, and cash reserves.
Main growth drivers
- Rising health consciousness and urbanization across Pakistan support long-term structural demand for private tertiary healthcare.
- Expansion of hospital infrastructure, bed capacity, and specialized clinics can drive higher patient volumes and revenue streams.
- Growth in corporate healthcare insurance panels and partnerships with multinational entities widen the addressable market.
Key risks to monitor
- High inflation and rising utility costs (electricity and gas) directly increase hospital operational overheads, potentially squeezing margins.
- Reliance on imported medical equipment, pharmaceuticals, and consumables exposes the company to exchange rate volatility and import restrictions.
- Regulatory changes regarding healthcare pricing, taxation, and drug price controls by government authorities can impact profitability.
- Intense competition from emerging private hospital chains in major urban centers may pressure pricing power and talent acquisition costs.
Opportunities
- Geographic diversification through satellite clinics, diagnostic centers, and regional hospitals can capture underserved markets outside Islamabad.
- Upgrading medical technology and introducing specialized robotic surgeries or advanced treatments can attract high-margin elective procedures.
- Tapping into medical tourism by offering competitive, high-quality international standard care to patients from neighboring regions.
Investor checklist
- Review the latest quarterly and annual financial reports published on the PSX website for up-to-date earnings, margins, and debt levels.
- Monitor macroeconomic indicators in Pakistan, particularly utility tariff adjustments, inflation rates, and the stability of the PKR.
- Assess management's strategy regarding capital expenditure, expansion timelines, and financing methods for future projects.
- Disclaimer: This profile is for educational and research purposes only and does not constitute guaranteed investment advice, price targets, or buy/sell instructions.
Advertisement
Ask the AI Analyst
Free. No login. Answers are grounded in the data shown on this page.